Conservative oxygen therapy in critically ill and perioperative period of patients with sepsis-associated encephalopathy

脓毒症相关脑病危重症患者及围手术期保守氧疗

阅读:1

Abstract

OBJECTIVES: Sepsis-associated encephalopathy (SAE) patients in the intensive care unit (ICU) and perioperative period are administrated supplemental oxygen. However, the correlation between oxygenation status with SAE and the target for oxygen therapy remains unclear. This study aimed to examine the relationship between oxygen therapy and SAE patients. METHODS: Patients diagnosed with sepsis 3.0 in the intensive care unit (ICU) were enrolled. The data were collected from the Medical Information Mart for Intensive Care IV (MIMIC IV) database and the eICU Collaborative Research Database (eICU-CRD) database. The generalized additive models were adopted to estimate the oxygen therapy targets in SAE patients. The results were confirmed by multivariate Logistic, propensity score analysis, inversion probability-weighting, doubly robust model, and multivariate COX analyses. Survival was analyzed by the Kaplan-Meier method. RESULTS: A total of 10055 patients from eICU-CRD and 1685 from MIMIC IV were included. The incidence of SAE patients was 58.43%. The range of PaO(2) (97-339) mmHg, PaO(2)/FiO(2) (189-619), and S(P)O(2)≥93% may reduce the incidence of SAE, which were verified by multivariable Logistic regression, propensity score analysis, inversion probability-weighting, and doubly robust model estimation in MIMIC IV database and eICU database. The range of PaO(2)/FiO(2) (189-619) and S(P)O(2)≥93% may reduce the hospital mortality of SAE were verified by multivariable COX regression. CONCLUSIONS: SAE patients in ICU, including perioperative period, require conservative oxygen therapy. We should maintain S(P)O(2)≥93%, PaO(2) (97-339) mmHg and PaO(2)/FiO(2) (189-619) in SAE patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。